首页> 美国卫生研究院文献>Bulletin of the World Health Organization >Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.
【2h】

Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.

机译:发展中国家不安全注射和血源性病原体传播:综述。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Unsafe injections are suspected to occur routinely in developing countries. We carried out a literature review to quantify the prevalence of unsafe injections and to assess the disease burden of bloodborne infections attributable to this practice. Quantitative information on injection use and unsafe injections (defined as the reuse of syringe or needle between patients without sterilization) was obtained by reviewing the published literature and unpublished WHO reports. The transmissibility of hepatitis B and C viruses and human immunodeficiency virus (HIV) was estimated using data from studies of needle-stick injuries. Finally, all epidemiological studies that linked unsafe injections and bloodborne infections were evaluated to assess the attributable burden of bloodborne infections. It was estimated that each person in the developing world receives 1.5 injections per year on average. However, institutionalized children, and children and adults who are ill or hospitalized, including those infected with HIV, are often exposed to 10-100 times as many injections. An average of 95% of all injections are therapeutic, the majority of which were judged to be unnecessary. At least 50% of injections were unsafe in 14 of 19 countries (representing five developing world regions) for which data were available. Eighteen studies reported a convincing link between unsafe injections and the transmission of hepatitis B and C, HIV, Ebola and Lassa virus infections and malaria. Five studies attributed 20-80% of all new hepatitis B infections to unsafe injections, while three implicated unsafe injections as a major mode of transmission of hepatitis C. In conclusion, unsafe injections occur routinely in most developing world regions, implying a significant potential for the transmission of any bloodborne pathogen. Unsafe injections currently account for a significant proportion of all new hepatitis B and C infections. This situation needs to be addressed immediately, as a political and policy issue, with responsibilities clearly defined at the global, country and community levels.
机译:怀疑在发展中国家经常发生不安全的注射。我们进行了文献综述,以量化不安全注射的发生率,并评估可归因于这种做法的血源性感染的疾病负担。有关注射使用和不安全注射的定量信息(定义为未经灭菌的患者之间重复使用注射器或针头),方法是查阅已发表的文献和未发表的WHO报告。乙型和丙型肝炎病毒以及人类免疫缺陷病毒(HIV)的传播能力是使用针刺伤害研究的数据估算得出的。最后,对所有将不安全注射和血源性感染联系起来的流行病学研究进行了评估,以评估应归因于血源性感染的负担。据估计,发展中国家每个人平均每年接受1.5次注射。但是,寄养的儿童以及生病或住院的儿童和成人,包括感染了艾滋病毒的儿童和成人,经常会受到10至100倍的注射次数。平均所有注射的95%是治疗性的,其中大多数被认为是不必要的。在有可用数据的19个国家中的14个国家(代表五个发展中国家区域)中,至少有50%的注射不安全。十八项研究报告说,不安全注射与乙型和丙型肝炎,艾滋病毒,埃博拉和拉沙病毒感染和疟疾的传播之间具有令人信服的联系。五项研究将所有新的乙型肝炎感染的20-80%归因于不安全的注射,而三项隐含的不安全注射是丙型肝炎的主要传播方式。总而言之,在大多数发展中国家地区,不安全的注射经常发生,这意味着任何血源性病原体的传播。目前,不安全注射占所有新的乙型和丙型肝炎感染的很大一部分。这种情况需要作为政治和政策问题立即加以解决,并在全球,国家和社区各级明确界定责任。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号